Recombinant human glucerebrosidase ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	2

19. ライソゾーム病

---

臨床試験数 : 854 /  薬物数 : 716 - (DrugBank : 105) / 標的遺伝子数 : 70 - 標的パスウェイ数 : 191

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-003685-32-ES (EUCTR)	27/01/2012	13/10/2011	NA	A Multicenter Extension Study of Taliglucerase alfa in Adult Subjects with Gaucher Disease - NA	Gaucher disease MedDRA version: 14.0;Level: PT;Classification code 10018048;Term: Gaucher's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]	Product Name: recombinant human glucerebrosidase Product Code: Taliglucerase Alfa INN or Proposed INN: Taliglucerase alfa Other descriptive name: prGCD	Protalix Biotherapeutics	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	25		Serbia;Canada;Mexico;Chile;Spain;Italy;South Africa;Israel
2	EUCTR2011-003676-37-ES (EUCTR)	15/11/2011	14/09/2011	NA	A Multicenter Extension Study of Taliglucerase alfa in Pediatric Subjects with Gaucher Disease - NA	Gaucher disease MedDRA version: 14.0;Level: PT;Classification code 10018048;Term: Gaucher's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]	Product Name: recombinant human glucerebrosidase Product Code: Taliglucerase Alfa INN or Proposed INN: Taliglucerase alfa Other descriptive name: prGCD	Protalix Biotherapeutics	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15		Spain;South Africa;Israel